Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thoracic Neoplasms × Ultrasonography × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Prostatic Neoplasms 6 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Liver Cirrhosis 2 Carcinoma, Hepatocellular 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Thoracic Neoplasms 1 Testicular Neoplasms 1 Solid Tumor 1 Renal Colic 1 Rectal Neoplasms 1 Pregnancy, Ectopic 1 Pneumonia 1 Pleural Effusion 1 Phlebitis 1 Penile Neoplasms 1 Mesothelioma 1 Melanoma 1 Margins of Excision 1 Lymphoma, Primary Effusion 1 Lymphoma, B-Cell 1 Lymphoma, AIDS-Related 1 Lung Neoplasms 1

Interventions

Carboplatin 10 pembrolizumab 5 Pemetrexed 5 osimertinib 4 Paclitaxel 4 durvalumab 3 atezolizumab 3 Cisplatin 3 selpercatinib 2 pralsetinib 2 entinostat 2 apatinib 2 Radiosurgery 2 Injections 2 Erlotinib Hydrochloride 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 sotorasib 1 sintilimab 1 repotrectinib 1 pegylated granulocyte colony-stimulating factor 1 patritumab 1 napabucasin 1 ficlatuzumab 1 efineptakin alfa 1 cobimetinib 1 ceralasertib 1 cemiplimab 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05321615 2023-10-25

Palpator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Unknown

Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡